1. Adler AL, Lee JY, Warner RB, Cowan C, Opgenorth TJ (1993) The angiotensin II antagonist Abott-81988 reverses hypertension and ventricular hypertrophy without altering lipid profile in SHR [abstract]. FASEB J 7: A245
2. Alderman MH (1992) Which antihypertensive drugs first and why? JAMA 267: 2786–2787
3. Anderson K, Neldam S (1997) A comparison of the antihypertensive effects of candesartan, cilexedl and losartan in patients with mild to moderate hypertension. J Hum Hypertens 11 (Suppl 2): S63–S64
4. Angiotensin II antagonist eprosartan. Satellite Symposium, American Society of Hypertension, San Francisco, CA, USA
5. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Menard J(1995) Additive effects of combined angiotensin converting enzyme inhibition and angiotensin II antagonisms on blood pressure and renin release in sodium depleted normotensives. Circulation 92: 825–834